| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Centessa Pharmaceuticals plc | Director | Ordinary Shares | 60,000 | $477,600 | $7.96 | 18 Nov 2021 | Direct |
| Avalo Therapeutics, Inc. | Director | Restricted Stock Units | 6,333 | $53,577 | $8.46 | 28 Mar 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Common Stock | 3,167 | $26,793 | $8.46 | 28 Mar 2025 | Direct |
| Tourmaline Bio, Inc. | Director | Common Stock | 0 | $0 | $47.83 | 28 Oct 2025 | Direct |
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 20,100 | 17 Jun 2025 | Direct | ||
| Tourmaline Bio, Inc. | Director | Employee Stock Option (Right to Buy) | 0 | 28 Oct 2025 | Direct | ||
| Tourmaline Bio, Inc. | Director | Stock Option (Right to Buy) | 0 | 05 Sep 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TRML | Tourmaline Bio, Inc. | 28 Oct 2025 | 3 | $0 | 4 | Director | 28 Oct 2025, 18:30 |
| TRML | Tourmaline Bio, Inc. | 24 Oct 2025 | 1 | $0 | 4 | Director | 24 Oct 2025, 18:10 |
| TRML | Tourmaline Bio, Inc. | 05 Sep 2025 | 4 | +$99,526 | 4 | Director | 09 Sep 2025, 18:00 |
| AVTX | Avalo Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 16:25 |
| TRML | Tourmaline Bio, Inc. | 04 Jun 2025 | 1 | $0 | 4 | Director | 06 Jun 2025, 16:41 |
| AVTX | Avalo Therapeutics, Inc. | 28 Mar 2025 | 2 | $0 | 4 | Director | 01 Apr 2025, 16:37 |
| AVTX | Avalo Therapeutics, Inc. | 13 Aug 2024 | 2 | $0 | 4 | Director | 14 Aug 2024, 16:36 |
| TRML | Tourmaline Bio, Inc. | 05 Jun 2024 | 1 | $0 | 4 | Director | 07 Jun 2024, 16:02 |
| AVTX | Avalo Therapeutics, Inc. | 28 Mar 2024 | 0 | $0 | 3 | Director | 03 Apr 2024, 16:01 |
| TALS | Tourmaline Bio, Inc. | 24 Oct 2023 | 1 | +$88,950 | 4 | Director | 26 Oct 2023, 17:00 |
| TALS | Tourmaline Bio, Inc. | 19 Oct 2023 | 3 | $0 | 4 | Director | 23 Oct 2023, 20:24 |
| TALS | Tourmaline Bio, Inc. | 19 Oct 2023 | 0 | $0 | 3 | Director | 23 Oct 2023, 18:31 |
| CNTA | Centessa Pharmaceuticals plc | 18 Nov 2021 | 1 | +$119,850 | 4 | Director | 18 Nov 2021, 19:30 |
| CNTA | Centessa Pharmaceuticals plc | 27 May 2021 | 0 | $0 | 3 | Director | 27 May 2021, 20:30 |